Notably, JNJ's Crohn's disease therapy Stelara, which is facing U.S. generics this year, added $2.35B to the topline with a ~15% YoY decline and fell short of Street forecasts, as did its ...

Nintendo Switch 2 has officially arrived, sort of. Eight years after Nintendo gave the world, what would eventually turn out to be its second highest-selling video game system (behind only the ...

We unpack all the twists in this week’s Season 2 premiere of “Severance”—and savor what looks like a spectacular return. Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...

The little hybrid console that could had a great run, playing host to some all-time classic games – but its time is now running short: the Nintendo Switch 2 is official, and coming very soon. The firm ...

Nintendo has officially revealed the Switch 2, its successor to the wildly popular Switch console. Like the original Switch, the Switch 2 is a hybrid home and handheld gaming console, but with ...

He joined The Verge in 2019 after nearly two years at Techmeme. Nintendo shared the first details about the Nintendo Switch 2 in a video published Thursday. Nintendo doesn’t give a specific ...

Rumors of a Nintendo Switch 2 have been circulating for years. Whispers of the next-gen Nintendo console first started when The Legend of Zelda: Tears of the Kingdom was initially teased in 2019 ...

Nintendo has finally revealed the Switch 2 with a video that confirms a number of new features while sparking burning questions for fans to discuss. While pre-announce leaks proved to be pretty ...

The Nintendo Switch 2 has been confirmed, and we'll find out more about it in a Nintendo Direct focused on the new console that's coming in early April. In a video released a few minutes ago ...

Liz Giuffre does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Johnson & Johnson is in talks to acquire Intra-Cellular Therapies Inc., a biopharmaceutical company focused on treatments for central nervous system disorders, people familiar with the matter said. A ...